BioSpace News Archive

Agilent Technologies Inc. (NYSE: A) will release fourth-quarter fiscal 2018 financial results after the stock market closes on November 19.

NX Prenatal, a privately held women’s healthcare molecular diagnostic company, announced today that it has entered into a collaboration with Indiana University School of Medicine to further validate its early pregnancy biomarker panels that predict Spontaneous Preterm Birth (SPTB) and to further develop its biomarker panels for Preeclampsia (PE).

Dave Carlson MBA, Ph.D., a standards-based solution architect with BookZurman and founder of Clinical Cloud Solutions, is advancing the maturity and innovative use of Fast Healthcare Interoperability Resources (HL7® FHIR® standard).

Versant Health announces that it has received the ISO 9001:2015 International Quality Standard certification for its lab in Newtown Square, PA.

DisposeRx Inc. (http://www.disposerx.com) celebrated a turning point in the opioid crisis today by joining President Trump at the White House as he signed into law a comprehensive legislative package designed to stem the nation’s opioid crisis.

Leidos Chairman and Chief Executive Officer Roger Krone today attended the signing of the “Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act” or SUPPORT for Patients and Communities Act at the White House, committing his support with other private industry executives to help end the opioid epidemic.

Act Broadens Access to Medication-Assisted Treatment for People Affected by Opioid Addiction

Visit Included Promotion of Private and Public Sector Efforts to Fight the Opioid Crisis, Signing of Recently Passed Opioid Legislation

Global health service company CIGNA Corporation (NYSE:CI) issued the following statement today at the White House signing ceremony for the SUPPORT for Patients and Communities Act, from Alan Muney, M.D., Cigna chief medical officer.

Company Has Collected More than 400 Tons of Unwanted Medications to Date